Data / Form D filings / AtheroNova Inc.
AtheroNova Inc.: Form D filings
AtheroNova Inc., a pharmaceuticals company in Irvine, CA, filed 8 Form D notices with the SEC between 2010 and 2014. The latest, on September 16, 2014, reports $500,000 sold of a $1 million offering to 7 investors.
Find out what AtheroNova Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2301 DUPONT DRIVE, SUITE 525, Irvine, CA, 92612
- Phone
- (949) 525-5471
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1377053
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2014 | New notice | $1,000,000 | $500,000 | $500,000 | 7 | Sep 12, 2014 | sec.gov |
| Mar 3, 2014 | Amendment | $2,000,000 | $1,906,500 | $93,500 | 31 | Jan 13, 2014 | sec.gov |
| Jan 22, 2014 | New notice | $1,400,000 | $350,000 | $1,050,000 | 2 | Jan 13, 2014 | sec.gov |
| Aug 21, 2013 | New notice | $4,000,000 | $270,000 | $3,730,000 | 3 | Aug 8, 2013 | sec.gov |
| Nov 1, 2012 | New notice | $5,000,000 | $2,925,000 | $2,075,000 | 35 | Oct 1, 2012 | sec.gov |
| Dec 20, 2011 | Amendment | $1,748,764 | $1,748,764 | $0 | 47 | Apr 10, 2011 | sec.gov |
| May 12, 2011 | New notice | $1,000,000 | $437,725 | $562,275 | 7 | Apr 10, 2011 | sec.gov |
| Jun 11, 2010 | New notice | $10,741,000 | $10,741,000 | $0 | 21 | May 13, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander W Polinsky | Director | |
| Thomas W Gardner | Executive Officer, Director | |
| Johan M Spoor | Director | |
| Paul W DiPerna | Director | |
| Boris W Ratiner | Director | |
| Gary W Freeman | Director | |
| Mark Selawski | Executive Officer | |
| Fred W Knoll | Director | |
| Chaim W Davis | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Sep 15, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AtheroNova Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.